Intech Investment Management LLC Makes New $245,000 Investment in Addus HomeCare Co. (NASDAQ:ADUS)

Intech Investment Management LLC acquired a new position in Addus HomeCare Co. (NASDAQ:ADUS) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 2,112 shares of the company’s stock, valued at approximately $245,000.

A number of other institutional investors have also added to or reduced their stakes in ADUS. UMB Bank n.a. boosted its stake in Addus HomeCare by 64.2% in the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after acquiring an additional 88 shares during the last quarter. Quest Partners LLC purchased a new position in Addus HomeCare in the second quarter valued at about $31,000. EntryPoint Capital LLC purchased a new position in Addus HomeCare in the first quarter valued at about $44,000. Innealta Capital LLC purchased a new position in Addus HomeCare in the second quarter valued at about $44,000. Finally, GAMMA Investing LLC boosted its stake in Addus HomeCare by 40.8% in the first quarter. GAMMA Investing LLC now owns 556 shares of the company’s stock valued at $57,000 after acquiring an additional 161 shares during the last quarter. 95.35% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

ADUS has been the topic of a number of research analyst reports. TD Cowen boosted their target price on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Macquarie began coverage on shares of Addus HomeCare in a research note on Friday, June 28th. They issued an “outperform” rating and a $136.00 target price on the stock. StockNews.com cut shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 7th. Oppenheimer upped their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. Finally, Royal Bank of Canada restated an “outperform” rating and set a $141.00 price target on shares of Addus HomeCare in a research note on Tuesday, September 3rd. One investment analyst has rated the stock with a sell rating and eight have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $128.29.

Insiders Place Their Bets

In other news, Director Esteban Lopez sold 500 shares of the stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the transaction, the director now owns 3,366 shares of the company’s stock, valued at approximately $429,165. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, Director Esteban Lopez sold 500 shares of the stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the transaction, the director now owns 3,366 shares of the company’s stock, valued at approximately $429,165. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the transaction, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. The disclosure for this sale can be found here. Insiders have sold 22,917 shares of company stock worth $3,050,082 in the last three months. 4.60% of the stock is currently owned by corporate insiders.

Addus HomeCare Price Performance

NASDAQ ADUS opened at $130.95 on Friday. Addus HomeCare Co. has a 1 year low of $78.35 and a 1 year high of $136.12. The stock has a market capitalization of $2.37 billion, a PE ratio of 32.49, a P/E/G ratio of 2.40 and a beta of 1.04. The company’s 50 day simple moving average is $128.25 and its two-hundred day simple moving average is $115.31.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, August 5th. The company reported $1.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.14. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The business had revenue of $286.90 million for the quarter, compared to analysts’ expectations of $284.90 million. During the same period in the prior year, the company posted $0.94 EPS. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. On average, research analysts anticipate that Addus HomeCare Co. will post 4.58 EPS for the current year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.